REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edward G Lakatta, M.D.
National Institute on Aging (NIA)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- University of Miami, School of Medicine
Miami, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- William Beaumont Hospital
Royal Oak, Michigan, United States
- Mayo Clinic, Rochester
Rochester, Minnesota, United States
- New York Methodist Hospital
Brooklyn, New York, United States
- Cornell University
New York, New York, United States
- Ny Presbyterian Hospital
New York, New York, United States
- Weill Medical College
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- Penn State Heart and Vascular Institute
Hershey, Pennsylvania, United States
- Nashville Cardiovascular Magnetic Resonance Institute
Brentwood, Tennessee, United States
- Virginia Commonwealth University Medical Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jan 2011
- Last update posted
- 9 May 2017
- Registered enrollment
- 223
- Registry id
- NCT00378352
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.